Search

everythinglearnresearchcommunity

for

Search:↓

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

SII is a useful and affordable tool to assess and monitor alopecia areata.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

IL-18 signaling helps mature Tregs move into the thymus.

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Mupirocin nanoparticle-loaded hydrogel is safe and effective for healing burn wounds.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.